RVL Pharmaceuticals plc (RVLPQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (900.00%)
Jan 24, 2025, 4:00 PM EDT
RVL Pharmaceuticals Revenue
RVL Pharmaceuticals had revenue of $8.26M in the quarter ending June 30, 2023, a decrease of -2.25%. This brings the company's revenue in the last twelve months to $36.92M, up 5.64% year-over-year. In the year 2022, RVL Pharmaceuticals had annual revenue of $49.72M with 184.10% growth.
Revenue (ttm)
36.92M
Revenue Growth
+5.64%
P/S Ratio
n/a
Revenue / Employee
295.35K
Employees
125
Market Cap
111.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |